Kevin Ens
Chief Executive Officer
Medical Sciences
Tevosol Inc.Â
Canada
Biography
Chief Executive Officer Kevin has over 28 years of experience in the biotechnology, therapeutics and medical device industries including positions in sales and marketing, business development, regulatory, operations and C-level management. He has negotiated major license, supply and co-development agreements with multinationals for medical devices, diagnostics, natural health product ingredients and pharmaceutical API’s. As a co-founder and chief executive, Kevin successfully started a clinical diagnostics company and led the development of a product from concept to market. He has M&A experience and was a key member of the team that took a Canadian vaccine company public on the TSE in 2001. Since 2008, Kevin has operated his own consulting business helping start-up and early-stage life science companies with strategy, business planning, business development and operational management. Kevin joined TEC Edmonton in 2013 as an Executive-in-Residence and joined Tevosol in January 2016 as full-time CE Chief Executive Officer Kevin has over 28 years of experience in the biotechnology, therapeutics and medical device industries including positions in sales and marketing, business development, regulatory, operations and C-level management. He has negotiated major license, supply and co-development agreements with multinationals for medical devices, diagnostics, natural health product ingredients and pharmaceutical API’s. As a co-founder and chief executive, Kevin successfully started a clinical diagnostics company and led the development of a product from concept to market. He has M&A experience and was a key member of the team that took a Canadian vaccine company public on the TSE in 2001. Since 2008, Kevin has operated his own consulting business helping start-up and early-stage life science companies with strategy, business planning, business development and operational management. Kevin joined TEC Edmonton in 2013 as an Executive-in-Residence and joined Tevosol in January 2016 as full-time CE
Research Interest
medical devices, diagnostics, natural health product ingredients and pharmaceutical API’s.